Your browser doesn't support javascript.
loading
Author Correction: An anti-LpqH human monoclonal antibody from an asymptomatic individual mediates protection against Mycobacterium tuberculosis.
Krishnananthasivam, Shivankari; Li, Hao; Bouzeyen, Rania; Shunmuganathan, Bhuvaneshwari; Purushotorman, Kiren; Liao, Xinlei; Du, Fengjiao; Friis, Claudia Guldager Kring; Crawshay-Williams, Felicity; Boon, Low Heng; Xinlei, Qian; Chan, Conrad En Zuo; Sobota, Radoslaw; Kozma, Mary; Barcelli, Valeria; Wang, Guirong; Huang, Hairong; Floto, Andreas; Bifani, Pablo; Javid, Babak; MacAry, Paul A.
Afiliação
  • Krishnananthasivam S; Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Li H; College of Veterinary Medicine, China Agricultural University, Beijing, China.
  • Bouzeyen R; Center for Infectious Disease Research, School of Medicine, Tsinghua University, Beijing, China.
  • Shunmuganathan B; Division of Experimental Medicine, University of California, San Francisco, USA.
  • Purushotorman K; Life Sciences Institute, National University of Singapore, Singapore, Singapore.
  • Liao X; Life Sciences Institute, National University of Singapore, Singapore, Singapore.
  • Du F; National Clinical Laboratory on Tuberculosis, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing Chest Hospital, Capital Medical University, Beijing, P.R. China.
  • Friis CGK; National Clinical Laboratory on Tuberculosis, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing Chest Hospital, Capital Medical University, Beijing, P.R. China.
  • Crawshay-Williams F; Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Boon LH; Molecular Immunity Unit, University of Cambridge, Department of Medicine, MRC Laboratory of Molecular Biology, Cambridge, UK.
  • Xinlei Q; Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Chan CEZ; Life Sciences Institute, National University of Singapore, Singapore, Singapore.
  • Sobota R; National Centre for Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.
  • Kozma M; Defence Medical and Environmental Research Institute, DSO National Laboratories, Singapore, Singapore.
  • Barcelli V; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
  • Wang G; Life Sciences Institute, National University of Singapore, Singapore, Singapore.
  • Huang H; Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Floto A; National Clinical Laboratory on Tuberculosis, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing Chest Hospital, Capital Medical University, Beijing, P.R. China.
  • Bifani P; National Clinical Laboratory on Tuberculosis, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing Chest Hospital, Capital Medical University, Beijing, P.R. China.
  • Javid B; Molecular Immunity Unit, University of Cambridge, Department of Medicine, MRC Laboratory of Molecular Biology, Cambridge, UK.
  • MacAry PA; Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
NPJ Vaccines ; 8(1): 136, 2023 Sep 25.
Article em En | MEDLINE | ID: mdl-37749097
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article